CreaCyte® rHSA as Excipient (Exbumin® by InVitria) is a chemically defined albumin that can be used as an injectable excipient to enhance the stability of therapeutic proteins, improve viral stability for vaccines and gene therapies, stabilize cells and tissues in cell therapy and regenerative medicine applications, and maintain tissue viability in cryopreservation and storage.
Typical Applications
- Therapeutic Protein Stabilization
- Cell & Gene Therapy
- Vaccines
- Regenerative Medicine
- Medical Devices
- Tissue & Cell Storage
Benefits at a glance
- Optimized for final formulation – Improved stability, shelf-life and thermal logistics for biopharmaceutical drug products
- Enhanced downstream processing – Increased virus yield and recovery in purification workflows
- Versatile excipient – Supports protein and viral stability (e.g., AAV, LV) as well as cell and tissue viability and preservation
- No adventitious agent testing – Animal-free rHSA eliminates raw material screening and viral testing
